Retrospective Analyses of TrakStar Database
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-120
SponsorNeuronetics
About this trial
In this study, real-world data will be used to better understand the effects patient characteristics, symptoms and TMS protocol parameters have on clinical outcomes with NeuroStar TMS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female reported in database and not an invalid entry
Age reported and not an invalid entry
Treatment date of November 01, 2008 or later.
Disqualifiers
None
Trial population
patients treated with NeuroStar Advanced TMS Therapy on or after November 1, 2008, and whose treatment information was entered in the Neuronetics TrakStar database.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
NeuroStar Advanced TMS Therapy System
Devicenon-invasive brain stimulation device
Treatment groups
156,000 Participants
are divided into 1 treatment groupGroup A: Patients treated with NeuroStar TMS1 intervention
Trial outcomes
Primary outcomes
1
Change in clinical assessment score from baseline to post-treatment
real-world efficacy of NeuroStar TMS in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9
Time frame
8 weeksSecondary outcomes
1
Age at baseline and its correlation to change in score post treatment
Determine the patient characteristics like age that are associated with clinical outcomes- PHQ-9 following NeuroStar TMS
Time frame
8 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov